Lista de obras - Elisabetta Loggi - Dominio Público Uruguay

Adaptive response in hepatitis B virus infection

artículo científico

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft

artículo científico publicado en 2008

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

article

Chronic hepatitis B: Are we close to a cure?

artículo científico

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

artículo científico publicado en 2012

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

artículo científico publicado en 2005

Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies

artículo científico publicado en 2015

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

artículo científico publicado en 2012

Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis.

artículo científico publicado en 2005

Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.

artículo científico publicado en 2003

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts

artículo científico publicado en 2007

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

artículo científico publicado en 2008

Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.

artículo científico publicado en 2010

Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome

artículo científico publicado en 2002

In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

artículo científico publicado en 2004

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.

artículo científico publicado en 2008

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

artículo científico publicado en 2014

Infections and Organ Transplantation

Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.

artículo científico publicado en 2003

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study

artículo científico publicado en 2009

Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients.

artículo científico publicado en 2014

Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool

article by Elisabetta Loggi et al published March 2012 in Journal of Hepatology

Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses

artículo científico publicado en 2006

Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.

artículo científico publicado en 2006

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.

artículo científico publicado en 2012

Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis

artículo científico publicado en 2012

Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.

artículo científico publicado en 2005

Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report

artículo científico publicado en 2009

Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

artículo científico publicado en 2006

Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.

artículo científico publicado en 2003

Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients

artículo científico publicado en 2011

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

artículo científico publicado en 2005

Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection

artículo científico publicado en 2008

Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial

artículo científico publicado en 2004

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.

artículo científico publicado en 2006

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

artículo científico publicado en 2013

Vitamins in the treatment of chronic viral hepatitis.

artículo científico publicado en 2011

Lista de obras de Elisabetta Loggi

Adaptive response in hepatitis B virus infection

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

Chronic hepatitis B: Are we close to a cure?

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis.

Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.

Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome

In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Infections and Organ Transplantation

Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study

Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients.

Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool

Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses

Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.

Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis

Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.

Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report

Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.

Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection

Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

Vitamins in the treatment of chronic viral hepatitis.